ArticleBlood2025
Rilzabrutinib, the first-in-class BTK inhibitor for ITP.
Marc MichelPubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it
ArticleBlood2025
Marc MichelPubMed ↗Publisher ↗
No numbers read from the abstract.